TODD BRADY

Profile

First Name

: TODD

Middle Name

:

Last Name

: BRADY

Related Companies
Titles
Company Name
Related People
DIRECTOR
NOVADIGM THERAPEUTICS INC
BOYD CLARK, MICHAEL TIMOTHY COOKE, GORDON DOUGLAS, JOHN EDWARDS, JR., FRED HANEY, TUOMAS HOLMBERG
DIRECTOR
ASMACURE, INC.
LISE BRETON, JEAN-PAUL CASTAIGNE, YVON CORMIER, MARTIN DRISCOLL, MARTIN GODBOUT, JOHN HENDERSON, LUC VACHON
DIRECTOR
EVOKE PHARMA INC
MATT D-ONOFRIO, CAM L. GARNER, SCOTT L. GLENN, DAVID A. GONYER, MALCOLM R. HILL, KENNETH J. WIDDER
DIRECTOR
SEBACIA, INC.
CHARLES ABRAHAM, TODD D. BRADY, JOHN DYETT, ANTHONY LANDO, ANTHONY V. LANDO, CHARLES LARSEN, CHARLES E. LARSON, ROBERT LESLIE, TODD MEYER, DILIP PAITHANKAR, DILIP PAITHANKER, REBECCA B. ROBERTSON, REBECCA S. ROBERTSON, JESSE TREU, GERARD VAN HAMEL PLATERINK, STEVEN WAITE, NEAL WALKER, THOMAS WELDON, THOMAS D. WELDON, GORDON WYATT, GORDON T. WYATT
EXECUTIVE OFFICER, DIRECTOR
ALDEXA THERAPEUTICS, INC.
TODD C. BRADY, BEN BRONSTEIN, GERALD CAGLE, DAVID L. CLARK, C. BOYD CLARKE, C.BOYD CLARKE, RICHARD DOUGLAS, JOHN DOWLING, MARTIN J. JOYCE, STEPHEN MACHATHA, DAVID MCMULLIN, GARY PHILLIPS, JOSHUA REED, JESSE I. TREU, STEPHEN TULIPANO, NEAL WALKER, ASISH XAVIER, SCOTT YOUNG, SCOTT L. YOUNG
EXECUTIVE OFFICER, DIRECTOR
RX GREEN SOLUTIONS LLC
JOHN BRADY, GEORGE MATELICH, WESLEY MATELICH
DIRECTOR
ONCOBIOLOGICS, INC.
GERD AUFFARTH, KENNETH M. BAHRT, TODD C. BRADY, SCOTT CANUTE, TERRY DAGNON, ALBERT D. DYRNESS, JEFF EVANSON, SCOTT A. GANGLOFF, JULIAN GANGOLLI, DONALD GRIFFITH, DONALD J. GRIFFITH, YEZAN HADDADIN, JULIA A. HALLER, KURT J. HILZINGER, ROBIN HOKE, ANDONG HUANG, LAWRENCE KENYON, LAWRENCE A. KENYON, STEPHEN J. MCANDREW, PANKAJ MOHAN, FAISAL G. SUKHTIAN, JOE THOMAS, RANDY THURMAN, RANDY H. THURMAN, C. RUSSELL TRENARY, ELIZABETH YAMASHITA
DIRECTOR
TYROGENEX, INC.
CHERYL CALHOUN, ADAM GOODFRIEND, JOHN IRWIN III, CHRIS LIANG, DENNIS PALMGREN, DENNIS L. PALMGREN, VINZENZ PLOERER, SHERIDAN SNYDER, SHERIDAN D. SNYDER, SHERIDAN G. SNYDER, JOSEPH STRAIGHT, TERI A. SWIFT, MICHAEL WEBB
DIRECTOR
THERABRON THERAPEUTICS, INC.
LINDA CHANG, CHRISTINE COPPLE, BLANCHE JOHNSON, BLANCHE M JOHNSON, BLANCHE M. JOHNSON, THOMAS MILLER, APRILE PILON-CLAYTON, APRILE L PILON-CLAYTON, APRILE L. PILON-CLAYTON, VINZENZ PLOERER, ERIC RICHMAN, JEFFREY ZELL, JEFFREY M ZELL, JEFFREY M. ZELL
DIRECTOR
AVIDITY BIOSCIENCES LLC
CARSTEN BOESS, SARAH BOYCE, MARK E. DAVIS, W. MICHAEL FLANAGAN, P. KENT HAWRYLUK, NOREEN HENIG, EDWARD KAYE, JEAN KIM, ARTHUR LEVIN, MICHAEL MACLEAN, MICHAEL MARTIN, MICHAEL MARTIN PHD., TERESA MCCARTHY, FRANK MCCORMICK, TAMAR THOMPSON, TROY WILSON, TROY WILSON PHD., JD, RODERICK WONG
DIRECTOR
GENO LLC
PAUL ANTINORI, ERIC BEDNARSKI, ROBERTO COHEN, KURT DASSE, DAVID FINE, DAVID H. FINE, PH.D., BRENT FURSE, BRENT V. FURSE, T. SCOTT JOHNSON, M.D., ANTHONY LOUMIDIS, THEO MELAS-KYRIAZI, JAMES O-BRIEN, VINZENZ PLOERER, ROBERT ROSCIGNO, DANIEL SALAZAR, DAN SALAZAR, PH.D., STEVEN SHULMAN, TOD SHULTZ, THIAGO TAVARES, SHASHA ZOU
EXECUTIVE OFFICER, DIRECTOR
ALDEYRA THERAPEUTICS, INC.
TODD C. BRADY, BEN BRONSTEIN, GERALD CAGLE, DAVID L. CLARK, C. BOYD CLARKE, C.BOYD CLARKE, RICHARD DOUGLAS, JOHN DOWLING, MARTIN J. JOYCE, STEPHEN MACHATHA, DAVID MCMULLIN, GARY PHILLIPS, JOSHUA REED, JESSE I. TREU, STEPHEN TULIPANO, NEAL WALKER, ASISH XAVIER, SCOTT YOUNG, SCOTT L. YOUNG
DIRECTOR
AVIDITY BIOSCIENCES, INC.
CARSTEN BOESS, SARAH BOYCE, MARK E. DAVIS, W. MICHAEL FLANAGAN, P. KENT HAWRYLUK, NOREEN HENIG, EDWARD KAYE, JEAN KIM, ARTHUR LEVIN, MICHAEL MACLEAN, MICHAEL MARTIN, MICHAEL MARTIN PHD., TERESA MCCARTHY, FRANK MCCORMICK, TAMAR THOMPSON, TROY WILSON, TROY WILSON PHD., JD, RODERICK WONG
DIRECTOR
VERO BIOTECH INC.
PAUL ANTINORI, ERIC BEDNARSKI, ROBERTO COHEN, KURT DASSE, DAVID FINE, DAVID H. FINE, PH.D., BRENT FURSE, BRENT V. FURSE, T. SCOTT JOHNSON, M.D., ANTHONY LOUMIDIS, THEO MELAS-KYRIAZI, JAMES O-BRIEN, VINZENZ PLOERER, ROBERT ROSCIGNO, DANIEL SALAZAR, DAN SALAZAR, PH.D., STEVEN SHULMAN, TOD SHULTZ, THIAGO TAVARES, SHASHA ZOU
EXECUTIVE OFFICER, DIRECTOR
HYPERFRAME INC.
MINAS APELIAN, JAY F. CADY, ALEXANDRIA LAFCI, KEN SOBEL, RYAN SUTTON-GEE
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-02-19
D
Link
MANUFACTURING 
 
DECLINE TO DISCLOSE 
Equity 
2025-12-31 
2022-04-05
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-23 
2021-12-22
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2021-12-08 
2019-11-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-11-08 
2019-02-11
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2019-01-28 
2017-09-29
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-09-01 
2017-07-25
D
Link
AGRICULTURE 
 
DECLINE TO DISCLOSE 
Equity 
2017-07-10 
2017-01-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-21 
2016-12-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-12-12 
2016-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-11 
2015-10-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-09-28 
2015-08-10
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2015-06-05 
2014-06-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2014-05-30 
2013-10-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-09-19 
2013-08-27
D
Link
AGRICULTURE 
 
DECLINE TO DISCLOSE 
Equity 
2013-08-26 
2013-02-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-06-25 
2013-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-12-20 
2012-04-11
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-29 
2011-10-20
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-06-25 
2011-06-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-20 
2011-05-18
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2011-05-06 
2010-06-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2010-06-16 
2010-02-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-28 
2009-12-16
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2008-06-25